Clinical Trials Finder
Independent ClinicalTrials.gov directory
ClinicalTrials.gov record
Recruiting Phase 1Phase 2 Interventional

A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations

ClinicalTrials.gov ID: NCT06706076

Public ClinicalTrials.gov record NCT06706076. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search
ClinicalTrials.gov public records Last synced May 19, 2026, 10:29 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1/2 Open-Label, Multicenter, First-in-Human Study of the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of BH-30643 in Adult Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations (SOLARA)

Study identification

NCT ID
NCT06706076
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
BlossomHill Therapeutics
Industry
Enrollment
266 participants

Conditions and interventions

Interventions

  • BH-30643 Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 8, 2025
Primary completion
Jan 30, 2029
Completion
Jul 30, 2029
Last update posted
Apr 23, 2026

2025 – 2029

United States locations

U.S. sites
23
U.S. states
15
U.S. cities
20
Facility City State ZIP Site status
Mayo Clinic Hospital - Arizona Phoenix Arizona 85054 Recruiting
The Regents of the University of California - Irvine, CA Campus Irvine California 92697 Recruiting
UC San Diego Moores Cancer Center La Jolla California 92093 Recruiting
University of California, Davis Comprehensive Cancer Center Sacramento California 95817 Recruiting
Stanford University Medical Center Stanford California 94305 Recruiting
Yale University - Cancer Center New Haven Connecticut 06520 Recruiting
Georgetown University Medical Center Washington D.C. District of Columbia 20007 Recruiting
Mayo Clinic - Florida Jacksonville Florida 32224 Recruiting
Sarah Cancer Research Institution - Florida Cancer Specialist Orlando Florida 32827 Recruiting
Moffitt Cancer Center Tampa Florida 33612 Recruiting
Northwestern Medicine - Northwestern Memorial Hospital Galter Pavilion Chicago Illinois 60611 Recruiting
Massachusetts General Hospital Boston Massachusetts 02214 Recruiting
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 Recruiting
Dana-Farber Cancer Institute Boston Massachusetts 02215 Recruiting
Henry Ford Health Detroit Michigan 48202 Recruiting
Mayo Clinic Hospital - Rochester, MN Rochester Minnesota 55905 Recruiting
Laura & Isaac Perlmutter Cancer Center at NYU Langone Health New York New York 10016 Recruiting
Memorial Sloan Kettering Cancer Center New York New York 10065 Recruiting
Thomas Jefferson University, Sidney Kimmel Cancer Center Philadelphia Pennsylvania 19107 Recruiting
Sarah Cannon Research Institute, LLC Nashville Tennessee 37203 Recruiting
The University of Texas - M.D. Anderson Cancer Center Houston Texas 77030 Recruiting
NEXT Virginia Fairfax Virginia 22031 Recruiting
Fred Hutchinson Cancer Center Seattle Washington 98109 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 18 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06706076, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 23, 2026 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06706076 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →